Current Status of Intranasal COVID-19 Vaccine, its Usage and Efficacy: A Narrative Review
The creation of a vaccine against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has received top focus worldwide. The majority of the COVID-19 vaccine candidates created is given Intramuscularly (IM). Intranasal (IN) vaccines offer a great benefit due to the first involvement of mucos...
Main Authors: | Ratan Tandon, Abhishek Joshi |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2023-05-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/17943/63348_CE[Ra1]_F[SK]_PF1(AG_SHU)_PFA(AG_KM)_PN(KM).pdf |
Similar Items
-
Oral and nasal vaccination: current prospects, challenges, and impact of nanotechnology-based delivery systems
by: Natália Floriano Paiva, et al.
Published: (2023-05-01) -
Vaccine Strategies to Elicit Mucosal Immunity
by: Yufeng Song, et al.
Published: (2024-02-01) -
Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity
by: Emil Joseph Vergara, et al.
Published: (2023-12-01) -
Polymeric Nanoparticles as Oral and Intranasal Peptide Vaccine Delivery Systems: The Role of Shape and Conjugation
by: Prashamsa Koirala, et al.
Published: (2024-02-01) -
An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response
by: Li Chen, et al.
Published: (2022-11-01)